Jane Street Group, LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $19.1 Million - $24.1 Million	154,000 New	154,000 $19.2 Million
Q1 2022 May 17, 2022	SELL	$63.15 - $90.42 $2.49 Million - $3.56 Million	-39,400 Reduced 49.81%	39,700 $3.1 Million
Q4 2021 Feb 15, 2022	BUY	$77.28 - $99.42 $1.1 Million - $1.41 Million	14,200 Added 21.88%	79,100 $7.12 Million
Q3 2021 Nov 16, 2021	BUY	$65.97 - $92.48 $178,119 - $249,696	2,700 Added 4.34%	64,900 $6 Million
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $10.9 Million - $13.6 Million	-157,200 Reduced 71.65%	62,200 $4.84 Million
Q1 2021 May 18, 2021	BUY	$72.25 - $168.95 $3.16 Million - $7.4 Million	43,800 Added 24.94%	219,400 $16.4 Million
Q4 2020 Feb 17, 2021	SELL	$125.56 - $178.74 $6.16 Million - $8.78 Million	-49,100 Reduced 21.85%	175,600 $29.9 Million
Q3 2020 Nov 17, 2020	BUY	$127.12 - $172.34 $21.9 Million - $29.6 Million	171,900 Added 325.57%	224,700 $31.6 Million
Q2 2020 Aug 17, 2020	BUY	$93.0 - $171.7 $4.4 Million - $8.12 Million	47,300 Added 860.0%	52,800 $8.47 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $2.87 Million - $4.58 Million	-34,800 Reduced 86.35%	5,500 $538,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $130,101 - $230,486	-1,700 Reduced 4.05%	40,300 $5.2 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $451,422 - $972,842	6,200 Added 17.32%	42,000 $3.16 Million
Q2 2019 Aug 15, 2019	BUY	$112.21 - $151.95 $1.01 Million - $1.37 Million	9,000 Added 33.58%	35,800 $5.44 Million
Q1 2019 May 16, 2019	BUY	$106.67 - $151.68 $2.56 Million - $3.64 Million	24,000 Added 857.14%	26,800 $3.19 Million
Q4 2018 Feb 15, 2019	SELL	$97.32 - $148.76 $10.4 Million - $15.8 Million	-106,500 Reduced 97.44%	2,800 $306,000
Q2 2018 Aug 15, 2018	BUY	$71.74 - $153.69 $7.53 Million - $16.1 Million	105,000 Added 2441.86%	109,300 $14.4 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $286,306 - $436,031	-5,300 Reduced 55.21%	4,300 $319,000
Q4 2017 Feb 15, 2018	SELL	$47.64 - $56.75 $9,528 - $11,350	-200 Reduced 2.04%	9,600 $534,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $350,153 - $462,070	9,800	9,800 $445,000

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.18 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.02 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$715 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$498 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$488 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account